Inventor
CLEVE ARWED
DE28 patents
⚠️ This page may combine multiple inventors who share the name “CLEVE ARWED”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING AG
16 patentsUS6316432B1Nov 13, 2001
Antigestagenically active steroids with a flourinated 17 α-alkyl chain
SCHERING AG40 citations95
US7148213B2Dec 12, 2006
Antigestagenically active steroids with a fluorinated 17α-alkyl chain
SCHERING AG18 citations92
US6806263B2Oct 19, 2004
Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain
SCHERING AG17 citations92
US6503895B2Jan 7, 2003
Antigestagenically active steroids with a fluorinated 17α-alkyl chain
SCHERING AG22 citations92
US5843933ADec 1, 1998
11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG31 citations92
US5843931ADec 1, 1998
6,7-modified 11β-aryl-4-oestrenes
SCHERING AG21 citations92
US5728689AMar 17, 1998
11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG18 citations92
US7138421B2Nov 21, 2006
Anti-androgenic pyrrolidines with tumor-inhibiting action
SCHERING AG14 citations83
US5426102AJun 20, 1995
14β-H-, 14-and 15-En-11β-aryl-4-oestrenes
SCHERING AG20 citations83
US5405979AApr 11, 1995
Process for the production of 10β-H-steroids
SCHERING AG15 citations74
US6767903B1Jul 27, 2004
New7α, 17α-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
SCHERING AG10 citations73
US6861432B2Mar 1, 2005
Piperazine derivatives that destabilize androgen receptors
SCHERING AG11 citations70
US5519027AMay 21, 1996
D-homo-(16-ene)-11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
SCHERING AG5 citations63
US5359054AOct 25, 1994
Initial compounds for the production of 10β-H-steroids and a process for the production of these initial compounds
SCHERING AG4 citations60
US6596713B1Jul 22, 2003
Steroid esters and amides, process for their production and their pharmaceutical use
SCHERING AG2 citations57
US6096732AAug 1, 2000
Steroid esters, process for their production and their pharmaceutical use
SCHERING AG0 citations52
Bayer Pharma AG
4 patentsUS10844016B2Nov 24, 2020
Aromatic sulfonamide derivatives
Bayer Pharma AG7 citations79
US10350206B2Jul 16, 2019
Benzyl substituted indazoles as BUB1 inhibitors
Bayer Pharma AG1 citations61
US9890147B2Feb 13, 2018
2,3-benzodiazepines
Bayer Pharma AG2 citations59
US11524938B2Dec 13, 2022
Aromatic sulfonamide derivatives
Bayer Pharma AG0 citations57
BAYER SCHERING PHARMA AG
3 patentsUS7601748B2Oct 13, 2009
Anti-androgenic pyrrolidines with tumor-inhibiting action
BAYER SCHERING PHARMA AG11 citations83
US8053426B2Nov 8, 2011
Progesterone receptor antagonists
BAYER SCHERING PHARMA AG12 citations78
US7910573B2Mar 22, 2011
Crystalline forms of 11β-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17α-pregna-4,9-dien-3-one
BAYER SCHERING PHARMA AG12 citations76